These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2049235)

  • 1. The pharmacokinetics of postoperative intravenous ketorolac tromethamine in children.
    Olkkola KT; Maunuksela EL
    Br J Clin Pharmacol; 1991 Feb; 31(2):182-4. PubMed ID: 2049235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of ketorolac tromethamine in humans after intravenous, intramuscular and oral administration.
    Jung D; Mroszczak E; Bynum L
    Eur J Clin Pharmacol; 1988; 35(4):423-5. PubMed ID: 3264245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ketorolac tromethamine pharmacokinetics and metabolism after intravenous, intramuscular, and oral administration in humans and animals.
    Mroszczak EJ; Jung D; Yee J; Bynum L; Sevelius H; Massey I
    Pharmacotherapy; 1990; 10(6 ( Pt 2)):33S-39S. PubMed ID: 2082311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of single-dose oral and intramuscular ketorolac tromethamine in the young and elderly.
    Jallad NS; Garg DC; Martinez JJ; Mroszczak EJ; Weidler DJ
    J Clin Pharmacol; 1990 Jan; 30(1):76-81. PubMed ID: 2303585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tolerability, central effects and pharmacokinetics of intravenous ketorolac tromethamine in volunteers.
    Lucker P; Bullingham R; Hooftman L; Lloyd J; Mroszczak E
    Int J Clin Pharmacol Ther; 1994 Aug; 32(8):409-14. PubMed ID: 7981925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nasal formulations of ketorolac tromethamine: technological evaluation--bioavailability and tolerability in rabbits.
    Santus G; Rivolta R; Bottoni G; Testa B; Canali S; Peano S
    Farmaco; 1993 Dec; 48(12):1709-23. PubMed ID: 8135994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ketorolac tromethamine.
    Med Lett Drugs Ther; 1990 Aug; 32(825):79-81. PubMed ID: 2199809
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical pharmacokinetics of ketorolac tromethamine.
    Brocks DR; Jamali F
    Clin Pharmacokinet; 1992 Dec; 23(6):415-27. PubMed ID: 1458761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmacokinetics of ketorolac enantiomers following intramuscular administration of the racemate.
    Hayball PJ; Wrobel J; Tamblyn JG; Nation RL
    Br J Clin Pharmacol; 1994 Jan; 37(1):75-8. PubMed ID: 8148223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ketorolac: a parenteral nonsteroidal antiinflammatory drug.
    Resman-Targoff BH
    DICP; 1990 Nov; 24(11):1098-104. PubMed ID: 2275236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ketorolac tromethamine absorption, distribution, metabolism, excretion, and pharmacokinetics in animals and humans.
    Mroszczak EJ; Lee FW; Combs D; Sarnquist FH; Huang BL; Wu AT; Tokes LG; Maddox ML; Cho DK
    Drug Metab Dispos; 1987; 15(5):618-26. PubMed ID: 2891477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative bioavailability of two oral formulations of ketorolac tromethamine: Dolac and Exodol.
    Flores-Murrieta FJ; Granados-Soto V; Castañeda-Hernández G; Herrera JE; Hong E
    Biopharm Drug Dispos; 1994 Mar; 15(2):129-36. PubMed ID: 8011965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of ketorolac and p-hydroxyketorolac following oral and intramuscular administration of ketorolac tromethamine.
    Jung D; Mroszczak EJ; Wu A; Ling TL; Sevelius H; Bynum L
    Pharm Res; 1989 Jan; 6(1):62-5. PubMed ID: 2717521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comments on ketorolac tromethamine for injection.
    Starnes CC; Hagler L
    Am J Hosp Pharm; 1993 May; 50(5):912. PubMed ID: 8506867
    [No Abstract]   [Full Text] [Related]  

  • 15. Ocular bioavailability and tissue distribution of [14C]ketorolac tromethamine in rabbits.
    Ling TL; Combs DL
    J Pharm Sci; 1987 Apr; 76(4):289-94. PubMed ID: 3598886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The excretion of ketorolac tromethamine into breast milk after multiple oral dosing.
    Wischnik A; Manth SM; Lloyd J; Bullingham R; Thompson JS
    Eur J Clin Pharmacol; 1989; 36(5):521-4. PubMed ID: 2787750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of ketorolac in the management of postoperative pain.
    DeAndrade JR; Maslanka M; Maneatis T; Bynum L; Burchmore M
    Orthopedics; 1994 Feb; 17(2):157-66. PubMed ID: 8190679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects on platelet functions and pharmacokinetics of azapropazone and ketorolac tromethamine given as single parenteral doses.
    Pallapies D; Peskar BA; Brune K; Geisslinger G
    Br J Clin Pharmacol; 1994 Apr; 37(4):335-9. PubMed ID: 8018454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of oral ketorolac in the rat.
    Granados-Soto V; Flores-Murrieta FJ
    Methods Find Exp Clin Pharmacol; 1995 Oct; 17(8):535-8. PubMed ID: 8749226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ketorolac, an injectable nonnarcotic analgesic.
    Litvak KM; McEvoy GK
    Clin Pharm; 1990 Dec; 9(12):921-35. PubMed ID: 2292174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.